Not exact matches
«An all - electronic format
with barcode scanning brings elements to increase
patient safety and decrease errors because the
patient and the unit
of blood are positively identified as well as matched against the provider's transfusion order,» says nursing informaticist Meg Furukawa.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured
patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs;
safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
Announced a clinical trial collaboration
with Pfizer, Inc. (Pfizer) to evaluate the
safety and efficacy
of the investigational combination
of Yescarta and Pfizer's utomilumab, a fully humanized 4 - 1BB agonist monoclonal antibody, in
patients with refractory large B - cell lymphoma.
We do this by conducting clinical trials in which we collect
safety and efficacy data about our experimental drugs
with the goal
of submitting those data to regulatory authorities, like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), so that these experimental drugs can be approved for use by
patients.
Presentations will highlight the short and long - term effects
of Ingrezza on tardive dyskinesia symptoms by body region, long term
safety and efficacy data from the KINECT 4 phase 3 open label study and also from RE-KINECT (real - world screening study
of patients with possible TD).
On and on it goes, where it stops, nobody knows: Now UK hospitals are being accused
of putting
patients» lives at risk by failing to comply
with safety orders from central control.
Palladio Group, together
with E Ink, was granted a Silver Award in the 28th DuPont Awards for Packaging Innovation for their
patient - forward packaging design for PhutureMed ™ — an excellent example
of packaging innovation that benefits the greater good by advancing
patient safety.
The HAI Education Program is part
of a national infection awareness campaign for healthcare professionals called «Not on My Watch» and provides facilities
with a toolkit that contains informational flyers,
patient safety tips and posters.
Women & Infants Hospital was one
of the first hospitals in the country to provide around - the - clock coverage for obstetrical
patients, and we maintain a record
of excellence
with respect to
patient care and
safety.
They started
with patient safety and showed that planned home birth has unnecessary, preventable, irremediable increased risk
of harm for pregnant, fetal, and neonatal
patients.
NHS England has today issued a
Patient Safety Alert rapidly notifying the healthcare system — and specifically midwives — to the possible risks associated
with the use
of these heated birthing pools at home.
The decision whether or not to continue naltrexone treatment for a woman already using naltrexone before pregnancy should involve a careful discussion
with the
patient that compares the limited
safety data versus the potential risk
of relapse
with treatment discontinuation.
With the imminent closure
of the National Programme for Healthcare Associated Infections (HCAIs) and the radical reform
of NHS services, it is vital that during the period
of change
patient safety remains at the forefront
of everyone's priorities.
«We are pleased to continue to work
with all parties to protect
patients and ensure the
safety and well - being
of thousands
of hospital workers and other health care professionals across the state,» the statement issued Wednesday afternoon read.
The bill, which passed unanimously in both chambers last June, would have narrowed the definition
of a
safety net to include: a public hospital,
with the exception
of SUNY; a federally designated critical access or sole community hospital; or a hospital that has at least 50 percent
of its
patients uninsured or on Medicaid, 40 percent
of its inpatient population covered by Medicaid, not more than 25 percent
of its discharges using commercial insurance, and at least 3 percent
of its
patients uninsured.
COMELS, a group
of medical laboratory scientists, together
with the
Patients Safety Advocacy Africa, condemned attempts by authorities
of the Hospital to privatize the Hospital's...
A group
of medical laboratory scientists calling itself the Concerned Medical Laboratory Scientists (COMELS), together
with the
Patients Safety Advocacy Africa, has condemned attempts by authorities
of the Tamale Teaching Hospital to privatize the Hospital's laboratory department.
«We are pleased to continue to work
with all parties to protect
patients and ensure the
safety and well - being
of thousands
of hospital workers and other health care professionals across the state.
They would argue it's a matter
of patient safety, but I would argue it's more to do
with an interest in not promoting competition.»
«Until we have further evidence on the efficacy
of medical cannabis for the treatment
of sleep apnea, and until its
safety profile is established,
patients should discuss proven treatment options
with a licensed medical provider at an accredited sleep facility,» said lead author Dr. Kannan Ramar, professor
of medicine in the division
of pulmonary and critical care medicine at Mayo Clinic in Rochester, Minnesota.
Further studies in animal models and
patients (
with altered TRPM7 channel function) have been initiated, in order to evaluate the efficacy and
safety of magnesium as a therapeutic for this disease.
The grant was to study what types
of computational systems, in conjunction
with physiological
patient monitors, could be implemented into vehicles to achieve the
safety objective.
The NAPOLI - 1 (NAnoliPOsomaL Irinotecan) Phase 3 study — a final confirmation
of a drug's
safety and effectiveness — was conducted among
patients with metastatic pancreatic cancer who previously received gemcitibine, which has been the standard -
of - care therapy for such
patients.
It is hard to understand why governments defend a system
with such a poor record, or why they are dismissive
of new technologies that promise increased
patient safety while decreasing the time and cost
of drug development, not to mention the savings to healthcare systems from fewer adverse drug reactions.
With A3AR drugs demonstrating good
safety profiles in clinical trials as anti-inflammatory and anti-cancer agents, Salvemini and colleagues are enthusiastic about the potential
of these new drugs to treat chronic pain in
patients.
Primarily supported by a $ 5.6 million grant from the The Michael J. Fox Foundation for Parkinson's Research and conducted at 17 sites across the U.S., SURE - PD (
Safety of URate Elevation in Parkinson's Disease) enrolled 75 recently diagnosed Parkinson disease
patients with relatively low blood levels
of urate (less than 6 mg / dL).
It typically takes many years to initiate such trials because
of the stringent
safety testing that must be done before testing in humans begins, but Reynolds said it may be possible to move faster as the therapy only involves modifying a
patient's dietary intake and supplementing
with a medium - chain triglyceride oil, both
of which have no known side effects.
The largest urban health systems, which serve as
safety nets for large
patient populations
with lower socioeconomic status and greater likelihood to speak English as a second language, do worse on government
patient satisfaction scores than smaller, non-urban hospitals likely to serve white customers
with higher education levels, according to a new study by Mount Sinai researchers published this month in the Journal
of Hospital Medicine.
They are launching a clinical trial to evaluate the
safety of their approach and gauge its effectiveness in
patients with lymphoma, a cancer
of the lymphatic system.
However, treatment
of pain and the administration
of opioids in the ED can be challenging for physicians because
of a lack
of familiarly
with the
patient, time constraints and concerns about
patient safety.
Respondents in this year's survey pointed to five main causes
of the field's less than favorable reputation: drug and product recalls such as the withdrawal
of Avandia;
safety issues such as the discovery
of problems
with raw material from China used in medical products; scandals, including evidence that pharmaceutical companies have failed to release data from trials whose results cast doubts on their drugs»
safety and efficacy; lawsuits brought against companies that failed to warn
patients of problems
with their products; and ethical issues such as kickbacks for physicians promoting specific medications.
For example, the results
of one study, known as UPLIFT, one
of four large - scale studies conducted in 2008, demonstrated the effectiveness and
safety of a drug called Spirivain about 6,000
patients with respiratory disease.
Further trials are planned to document the efficacy and
safety of the combination in
patients infected
with the other HCV genotypes and in particularly vulnerable groups, to enable a public health approach to the treatment
of hepatitis C.
«While Massachusetts
safety - net hospitals (many
of which are minority - serving) received large cuts in payments
with the idea that other hospitals would assume the care
of previously uninsured
patients, this study demonstrates the importance
of securing the future
of safety - net and minority - serving hospitals through policy - based interventions to assure the continued care
of vulnerable and underserved
patient populations.»
They base their findings on an analysis
of cases submitted between 2005 and 2012 to the National Reporting and Learning System (NRLS)-- a database
of patient safety incidents associated
with the delivery
of healthcare across the NHS in England and Wales.
Wyss - Coray was critical
of this trial, but Alkahest, a company he co-founded, recently completed its own more rigorous small
safety trial on 18 Alzheimer's
patients with «no adverse side effects.»
For instance, from the manufacturer's point
of view, an «improvement in the
safety of health care» and a «better integration
of patients with hemophilia into a normal social life» already arise through market entry.
In a phase 1b clinical trial
with 21
patients, researchers tested the
safety and efficacy
of combining the immunotherapy drug pembrolizumab
with an oncolytic virus called T - VEC.
The data
safety monitoring board
of the trial, as mandated by the study protocol, continues to monitor outcomes in
patients with a Recurrence Score
of 11 to 25 randomized to chemo - endocrine therapy or endocrine therapy alone.
The National Institutes
of Health (NIH) is planning a leadership overhaul at its hospital after an outside review found widespread problems
with patient safety.
The Suleman brouhaha showed that even routine uses
of reproductive technologies can be fraught
with issues that bear on ethics and
patient safety.
«Through this research we have found and established an equally effective means
of accomplishing the same goal
with an added layer
of safety for
patients.»
«Licensure is critical because it will ensure the quality, consistency and
safety of the islet product; provide greater
patient access to islet transplantation; and accelerate continued research that we hope would make this procedure suitable for a broader population
of people
with type 1 diabetes.»
A clinical trial in the Republic
of Korea for
patients with degenerative eye diseases is the first to test the
safety of an embryonic stem cell therapy for people
of Asian descent.
«In order to ensure the
safety of patients, further research is still vital to ensure that our findings can be repeated
with different groups
of doctors and
patients.
In a
Safety Communication in 2013, the agency said that it «is not aware
of any
patient injuries or deaths associated
with these incidents nor do we have any indication that any specific devices or systems in clinical use have been purposely targeted at this time.»
AHRQ is the lead federal agency charged
with improving
patient safety and the quality
of America's health care system.
«Currently, most victims
of elder abuse and neglect pass through our emergency departments
with a life - threatening condition unidentified,» said the latter paper's lead study author, Tony Rosen, MD, MPH,
of Weill Cornell Medical College in New York, N.Y. «A multi-disciplinary, team - based approach supported by additional research and funding has the potential to improve the identification
of elder abuse and improve the health and
safety of our most vulnerable
patients.»
«By considering that stethoscopes are used repeatedly over the course
of a day, come directly into contact
with patients» skin, and may harbor several thousands
of bacteria (including MRSA) collected during a previous physical examination, we consider them as potentially significant vectors
of transmission,» commented lead investigator Didier Pittet, MD, MS, Director
of the Infection Control Program and WHO Collaborating Centre on
Patient Safety, University
of Geneva Hospitals.
«The recommendations developed by our work groups should be paired
with those issued by the Institute
of Medicine (IOM) in 2011 in its report «Health IT and
Patient Safety: Building Safer Systems for Better Care,»» said Dr. Farley.